Biochemistry

M. Camps, C. Hou, D. Sidiropoulos, J.B. Stock, K.H. Jakobs, P. Gierschik, "Stimulation of phospholipase C by guanine nucleotide-binding protein bg subunits," European Journal of Biochemistry, 206:821-31, 1992. Montserrat Camps (Molecular Pharmacology Division, German Cancer Research Center, Heidelberg, Germany): "This work was done in the laboratory of Peter Gierschik at the University of Heidelberg department of pharmacology. We w

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Montserrat Camps (Molecular Pharmacology Division, German Cancer Research Center, Heidelberg, Germany): "This work was done in the laboratory of Peter Gierschik at the University of Heidelberg department of pharmacology. We were studying the regulation of phosphoinositide-specific phospholipases C (PI-PLCs) by signal-transducing heterotrimeric (a,bg) guanine nucleotide-binding proteins (G-proteins). G-proteins couple a large variety of cell-surface receptors to second messenger-generating effectors such as PI-PLC. In certain cells--for example, granulocytes--receptor-mediated stimulation of PI-PLC is blocked by pertussis toxin, while in other cells it is not. In 1990-91, PI-PLC was shown to be regulated by members of the aq subfamily of the G-protein a- subunits in pertussis toxin-resistant systems. In contrast, the pertussis toxin-sensitive pathway of PI-PLC stimulation

remained obscure until the publication of our work in 1992. "In this paper, we report that a PI-PLC present in cultured human HL-60 granulocytes is stimulated by G-protein bg- subunits, rather than by a-subunits. This finding ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies